SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (466)3/11/1999 1:25:00 AM
From: mike head  Read Replies (1) of 613
 
Odd, but I find the "raging" sorta dated/superficial. Like 'internut' hot-stocks, many analysts fall back on Buzzwords; not really much connection between "Genomics" and "Pharmecogenomics", really, if you stop and think about it! Both of these Buzzwords are transitory- and will mean something subtely different next month. In my vocabulary- and knowing that it's elusive/transitory- it's a safe bet to go with Pharmacogenomic/genetic Stocks! All, in my very HO, of course. Pax et Bonum, mch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News